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abstract

Article history:

Alcohol abuse results in liver injury, but investigations into the mechanism(s) for this injury
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have been hampered by the lack of appropriate in vitro culture models in which to conduct in
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depth and specific studies. In order to overcome these shortcomings, we have developed the
use of precision-cut liver slices (PCLS) as an in vitro culture model in which to investigate how
ethanol causes alcohol-induced liver injury. In these studies, it was shown that the PCLS
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retained excellent viability as determined by lactate dehydrogenase and adenosine tripho-

Precision-cut liver slice

sphate (ATP) levels over a 96-h period of incubation. More importantly, the major enzymes

Alcoholic liver disease

of ethanol detoxification; alcohol dehydrogenase, aldehyde dehydrogenase, and cyto-

Fatty liver

chrome P4502E1, remained active and PCLS readily metabolized ethanol and produced

Acetaldehyde

acetaldehyde. Within 24 h and continuing up to 96 h the PCLS developed fatty livers and

Ethanol metabolism

demonstrated an increase in the redox state. These PCLS secreted albumin, and albumin
secretion was decreased by ethanol treatment. All of these impairments were reversed
following the addition of 4-methylpyrazole, which is an inhibitor of ethanol metabolism.
Therefore, this model system appears to mimic the ethanol-induced changes in the liver
that have been previously reported in human and animal studies, and may be a useful model
for the study of alcoholic liver disease.
# 2008 Elsevier Inc. All rights reserved.

§

Supported by: National Institutes of Health Grants R01 AA10435, R37 AA07818, and R21 AA15505-01A2. Also supported by the
Department of Veterans Affairs National Merit Review Program and the Department of Internal Medicine at the UNMC.
§§
All work was performed in the Experimental Immunology Laboratory at the Omaha Veterans Administration Medical Center, Research
Services 151, 4101 Woolworth Avenue, Omaha, NE 68105.
* Corresponding author at: Omaha Veterans Administration Medical Center, 4101 Woolworth Avenue, Omaha, NE 68105, United States.
Tel.: +1 402 995 3550; fax: +1 402 449 0604.
E-mail address: mduryee@unmc.edu (M.J. Duryee).
Abbreviations: ATP, adenosine triphosphate; LDH, lactate dehydrogenase; 4-MP, 4-methylpyrazole; AA, acetaldehyde; ALD, alcohol
liver disease; ADH, alcohol dehydrogenase; ALDH, aldehyde dehydrogenase; CYP2E1, cytochrome P450 2E1; PCLS, precision-cut liver
slices.
0006-2952/$ – see front matter # 2008 Elsevier Inc. All rights reserved.
doi:10.1016/j.bcp.2008.05.012

biochemical pharmacology 76 (2008) 426–436

1.

Introduction

Alcohol abuse causes abnormalities in liver structure and
function, including fatty liver, apoptosis, necrosis, fibrosis,
and cirrhosis [1,2]. Despite numerous studies over the
years, the mechanisms of alcohol hepatotoxcity remain
unclear. Traditionally, ethanol-feeding animal models
have been used to study the physiological responses in
the liver. Although studies with this model have provided a
wealth of information, detailed mechanistic studies
are problematic using this in vivo model. Therefore,
several in vitro culture systems have been developed in
order to determine the effects of ethanol administration on
the liver. These systems include primary hepatocyte
cultures [3,4], HepG2 hepatoma cells expressing stable
exogenous alcohol dehydrogenase [5,6] or cytochrome
P4502E1 [7], and WIF-B cells [8,9]. Although these models
have provided valuable information, numerous limitations
and weaknesses are evident in these systems. For example,
differentiated functions are rapidly lost, cell–cell and cell–
matrix interactions are compromised, and most importantly
other cell types in the liver besides heptatocytes are not
present.
In view of the limitations of the currently established in
vitro culture systems for mechanistic studies of ethanol
hepatotoxicity, precision-cut liver slices (PCLS) were chosen
in this study as a possible model of alcoholic liver disease.
PCLS have been used previously for a variety of metabolic and
toxicological studies [10–13], and appear to be applicable for
ethanol hepatotoxicity studies. In this model, normal lobular
hepatic architecture is maintained, and the cell–cell and cell–
matrix interactions mimic the in vivo situation. In addition
and most importantly, PCLS contain hepatocytes and the
other non-parenchymal cells of the liver, namely Kupffer
cells, endothelial cells, and stellate cells. Since these other
cell types likely contribute to the deleterious effects of
ethanol [2], it would appear that PCLS could be a valuable
model to further delineate the mechanism(s) of ethanolinduced liver injury.
The purpose of this study was to validate the use of PCLS as
a model to investigate ethanol hepatotoxcity. Ethanol metabolism and steady state levels of acetaldehyde were determined in this model. In addition, the ability to reproduce some
of the known effects of ethanol on the liver; such as, formation
of a fatty liver, altered hepatic redox state, and impaired
albumin secretion, were investigated.

2.

Materials and methods

2.1.

Rats

Male Wistar rats were purchased from Charles River
Laboratories (Willmington, MA) and maintained on a Purina
rat chow diet. All animals were allowed free access to their
food and/or water up to 1 h prior to sacrifice. All procedures
were approved by the Animal Subcommittee of the Omaha VA
Medical Center, and are in accordance with the National
Institutes of Health Guidelines on the Use of Laboratory
Animals.

2.2.
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Rat precision-cut liver slices

Rats weighing 200–300 g were anesthetized using Isoflurane.
The basic method of Olinga et al. [14] was used to prepare the
PCLS. Briefly, the abdominal cavity was scrubbed with
betadine and entered exposing the liver. The inferior vena
cava was clipped, blood allowed to drain for 1 min, the liver
excised and quickly placed into oxygenated V-7 cold preservation buffer purchased from Vitron Inc. (Tucson, AZ).
Multiple (8 mm) cylindrical tissue cores were cut using a hand
held coring tool, loaded into the Vitron Tissue SlicerTM from
Vitron Inc. (Tucson, AZ), and 250 mm thick slices were
prepared [15]. Slices were cut using a 45-mm rotary blade,
floated into ice cold oxygenated V-7 preservation buffer, and
pre-incubated in the presence of serum free Williams Medium
(WE) (Sigma Chemical Co., St. Louis, MO) containing D-glucose
and gentamicin with 95% oxygen/5% CO2 (carbogen) at 37 8C
for 30 min. For some studies, slices were taken at this time
point and were designated as Time 0 (t0) slices. The rest of the
slices were loaded onto titanium-screen rollers from Vitron,
Inc. (Tucson, AZ) and inserted into sterile 20 ml glass vials
containing 1.7 ml of WE media. The vials were capped with lids
containing a 1 mm hole for the infusion of oxygen. This
assembly was placed horizontally into the Dynamic Organ
Culture incubator from Vitron Inc. (Tucson, AZ) and incubated
at 37 8C in the presence of carbogen using a flow rate of
1.5 lpm.

2.3.

Incubation of slices with ethanol

Following pre-incubation with WE, slices were incubated with
media only (control), media + 25 mM ethanol (ethanol), media + 25 mM ethanol + 0.50 mM 4-methylpyrazole (ethanol + 4MP), or media + 0.50 mM 4-methylpyrazole (control + 4-MP).
The addition of 4-MP was used in these studies as it is a general
inhibitor of ethanol metabolism. These slices were placed in
the Dynamic Organ Culture incubator and cultured at 37 8C for
up to 96 h, and every 24 h the appropriate media was
replenished. In order to determine the concentration of
ethanol and acetaldehyde in the media, the supernatant
was analyzed using headspace gas chromatography [16].

2.4.

Viability assays

Slice viability was determined by measuring adenosine
triphosphate (ATP) and lactate dehydrogenase (LDH) levels.
For the ATP assay, slices were harvested at the appropriate
times, placed into 70% ethanol/2 mM EDTA, flash frozen, and
stored at 70 8C until assayed. Samples were thawed on ice,
sonicated, and diluted in 0.1 M Tris–HCl/2 mM ETDA prior to
use in the ATP Bioluminescence Assay Kit CLSII (Roche
Applied Science, Penzberg, Germany). ATP levels were
detected using a Modulus Microplate Luminometer from
Turner Biosystems (Sunnyvale, CA).
For LDH determination, supernatant was collected and
frozen at 70 8C. The slice was solubilized in WE containing 2%
Triton X-100 and LDH determined using a Cytotoxicity
Detection Kit (LDH) (Roche Applied Science, Penzberg, Germany). The absorbance of the samples was measured at
490 nm using a MRX II plate reader with Revelation SoftwareTM
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(Dynex Technologies, Chantilly, VA). All protein concentrations from the slices were determined using a BCA Protein
Assay kit from Pierce (Rockford, IL). To calculate the %
Cytotoxicity at subsequent 24 h time points, the LDH in the
media was divided by the total LDH in the PCLS and multiplied
by 100.

2.5.

ADH/ALDH activity

Slices were harvested at the time points indicated, washed in
PBS (pH 7.4), lysed in 1% Triton X-100, and sonicated. For the
ADH assay, protein concentrations were adjusted to 50–100 mg
and incubated at 37 8C in the presence of 10 mM ethanol, 3 mM
NAD+, and 0.5 M Tris–HCl (pH 7.4). Conversion of NAD+ to
NADH was measured by the change in optical density at
340 nm using a Cary 50 spectrophotometer (Varian Inc., Palo
Alto, CA) [17]. ALDH activity was determined by placing the
slice into 1 ml of buffer containing 100 mM NaPO4 (pH 7.4),
3 mM NAD+, and 10 mM pyrazole. The reaction was initiated
by adding propionaldehyde to a final concentration of 25 mM
(low Km enzyme) or 1 mM (total enzyme activity). Conversion
of NAD+ to NADH was determined by the change in optical
density at 340 nm using a Cary 50 spectrophotometer [6].

2.6.

Cytochrome P450 2E1 (CYP2E1) assay

Microsomes were prepared from slices using a modified
protocol from Omura and Kamth et al. [18,19]. Briefly, slices
were added to a 1.15% KCl solution, sonicated, subjected to
differential centrifuged to obtain the microsomal fraction, and
protein concentration determined by the method of Lowry
et al. [20]. CYP2E1 activity was determined using the pnitrophenol (PNP) (Sigma Chemical Co., St. Louis, MO)
oxidation assay described by Wu and Cederbaum [21].
Microsomal protein was added to 0.2 mM PNP, 1 mM NADPH
(Sigma Chemical Co., St. Louis, MO), and incubated at 37 8C for
1 h. The reaction was stopped using 30% trichloroacetic acid,
centrifuged, and 10N NaOH was added to the remaining
supernatant. Activity was obtained by measuring the absorbance at 546 nm using a Beckman DU-70 spectrophotometer.
Immunoblotting techniques were used to determine
microsomal CYP2E1 expression [9]. Microsomal protein
(5 mg) was loaded onto a 10% SDS polyacrylamide gel,
transferred onto PVDF membrane, and blocked in Blotto.
The primary antibody, rabbit anti-CYP2E1 (Chemicon, Temecula, CA) was incubated overnight at 4 8C followed by 1 h
incubation with an IR-labeled secondary anti-rabbit IgG
antibody. Blots were washed, dried and scanned using an
Odyssey IR Scanner (Li-Cor, Lincoln, NE). Densitometric
analysis was performed using Odyssey imaging software (LiCor, Lincoln, NE) and the data are expressed in arbitrary
densitometric units/mg of protein.

2.7.

Cellular redox state and albumin secretion

Supernatant from liver slices incubated up to 96 h under
various conditions was assayed for the presence of lactate or
pyruvate using assay kits from Biovision (Mountain View, CA)
to assess the cellular redox state. Briefly, 50 ml/well of each
sample was incubated with 50 ml/well of assay kit reagent in

conjunction with the lactate or pyruvate enzyme. The reaction
was allowed to take place for 30 min and the levels of lactate or
pyruvate were determined by absorbance at 570 nm. Plates
were analyzed using a MRX II plate reader with Revelation
Software (Dynex Technologies, Chantilly, VA).
Supernatant was used to analyze PCLS for albumin
secretion using a Rat Albumin Quantitative ELISA Kit from
Bethyl Laboratories, Inc. (Montgomery, TX). This assay was
performed by coating a 96 well plate with a capture antibody
(sheep anti-Rat Albumin). Plates were blocked with BSA, and
the albumin standard or sample were added. A secondary
antibody was added (HRP conjugated Sheep anti-Rat Albumin)
and the plate was developed using TMB peroxidase substrate
(Pharmingen, San Diego, CA). Absorbance was detected at
450 nm using a MRX II plate reader with Revelation Software
(Dynex Technologies, Chantilly, VA).

2.8.

Triglyceride analysis

At indicated time points, supernatant was removed and slices
were washed in PBS (pH 7.4). Slices were placed in PBS
containing 0.5% Triton-X100, sonicated, and the equivalent of
300 mg of protein was assayed for triglycerides using the serum
triglyceride kit from Sigma Chemical Co. (St. Louis, MO).
Triglycerides in each sample were hydrolyzed by lipase and
the resulting free glycerol was calculated against a glycerol
standard at 540 nm using the Cary 50 spectrophotometer.

2.9.

Oil Red O staining

For Oil Red O staining, slices were flash frozen in OCT (Sigma
Chemical Co., St. Louis, MO), sectioned and gently placed onto
slides. Oil Red O was incubated with the sections, washed, and
the presence or absence of fat content analyzed by light
microscopy on a Nikon Microphot-FXA microscope by a
pathologist. Photographs were taken using a Colorview II
Olympus Camera with Analysis Software, at a final magnification of 325.

2.10.

Statistical analysis

The results are expressed as means  S.E.M. Statistical
significance was achieved if P-values were less than 0.05. All
statistical analysis was performed using the SigmaStat (Jandel
Scientific, 2002) program and one-way or multiple ANOVA
where appropriate.

3.

Results

The first step in assessing the utility of precision-cut liver
slices as a model of alcoholic liver disease (ALD) was to
determine their viability under different conditions and for
various lengths of time. Therefore, PCLS were prepared and
their viability over a 96-h period assessed using adenosine
triphosphate levels and lactate dehydrogenase release. ATP
was chosen as it represents the ability of the slices to maintain
an energy source and as such is a measure of live cells. In
contrast, cell death was quantified by measuring the amount
of LDH released into the medium. These assays represent two
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Fig. 1 – ATP production from rat precision-cut liver slices
(PCLS). PCLS were cultured at t0, 24, 48, 72 and 96 h in the
absence of ethanol (control), presence of 25 mM ethanol
(ethanol), absence of 25 mM ethanol but in the presence of
0.50 mM 4-MP (control + 4-MP), and in the presence of both
25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). ATP
activity was determined as described in Section 2. Data are
expressed as the mean (rmol ATP/mg of PCLS protein) W
S.E.M. of five separate experiments. There were no
significant differences observed at the various time points
among the four groups.

different ways of measuring viability. At time 0 (t0) all slices
showed a decreased level of ATP (approximately 4.5–5.6 pmol
ATP/mg of protein). PCLS at this time (30 min of pre-incubation)
most likely reflects acute changes related to the process of the
preparing the liver, physical trauma during the slicing, and a
‘‘washout’’ period during which the PCLS are equilibrating.
However, as shown in Fig. 1, all liver slices produced ATP and
maintained these levels over the 96-h period.
Measurement of LDH activity (Fig. 2) showed that cell death
(% Cytotoxicity) in control PCLS was maintained between 0
and 7.8% for up to 96 h. Incubation with 25 mM ethanol
increased the levels of cytotoxicity reaching a maximum of
11.9% at 72 and 96 h. These levels were significantly different
from control levels at all time points assayed. The addition of
4-methyl-pyrazole (4-MP) to the control and ethanol treated
samples resulted in a decrease in the % Cytotoxicity in both
control and ethanol-treated samples.
Ethanol metabolism and ADH activity were next examined
at the different time points (Fig. 3). At time zero, media
containing 25 mM ethanol was added. Every 24 h thereafter,
the media was totally removed and replaced with fresh media
containing 25 mM ethanol. In this way, it was possible to
assess how much ethanol was metabolized over a 24-h period.
During the first 24 h, the PCLS metabolized (as determined by
gas chromatography) 15.18 mmol/(24 h mg) of PCLS protein
and this level was maintained for the next 48 h (48 and 72 h
time points). At 96 h the PCLS appear to have a decrease in
their ability to metabolize ethanol to 9.43 mmol/(24 h mg) of
PCLS protein which may be related to the decrease in viability.
The addition of 4-MP to PCLS treated with ethanol at the onset
of the experiment to determine whether the clearance of
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Fig. 2 – LDH activity in rat pecision-cut liver slices. PCLS
were cultured at t0, 24, 48, 72 and 96 h in the absence of
ethanol (control, open circles), presence of 25 mM ethanol
(ethanol, closed triangles), absence of 25 mM ethanol but
in the presence of 0.50 mM 4-MP (control + 4-MP-closed
circles), and in the presence of both 25 mM ethanol and
0.50 mM 4-MP (ethanol + 4-MP-closed squares). LDH
activity (% Cytotoxicity) was determined as described in
Section 2. Data are expressed as the mean %
Cytotoxicity W S.E.M. of five separate experiments.
Ethanol significantly increased the % Cytotoxicity when
compared to other three groups, *P < 0.05. Ethanol and
control PCLS groups compared to ethanol + 4-MP or
control + 4-MP PCLS. Additionally, the control PCLS
showed significantly higher % Cytotoxicity compared to
the ethanol + 4-MP or control + 4-MP PCLS, #P < 0.05.

ethanol was due to metabolism showed that the metabolic
rate of ethanol was significantly decreased at all times
examined.
The metabolism of ethanol in the liver is primarily
dependent upon ADH activity. At 48, 72 and 96 h the ADH
activity of PCLS exposed to ethanol was decreased when
compared to control and ethanol + 4-MP treated slices, but
were only significantly lower at 72 and 96 h (Table 1). All ADH
activities were lower than at time 0, but were only significantly
lower for all slices at 72 and 96 h.
Ethanol metabolism by the liver produces acetaldehyde, an
extremely reactive compound implicated in ethanol-induced
liver injury [9,22–24]. Based on the results above, the
production of acetaldehyde was investigated. As shown in
Fig. 4, acetaldehyde levels were detectable within 24 h reaching about 4.2 mM concentrations and continued to increase at
48 (22.9 mM), 72 (47.1 mM) and 96 (64.3 mM) h. The production of
acetaldehyde was completely inhibited by the addition of
0.50 mM 4-MP, indicating the acetaldehyde produced was
from ethanol metabolism.
Because the levels of acetaldehyde are partially dependent
upon their metabolism by cellular ALDH enzymes, the total
and low Km ALDH activities were investigated (Table 1). The
total ALDH enzyme activities of PCLS treated under all
conditions showed significantly lower activities when compared to t0. Additionally, total ALDH activity was further
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Fig. 3 – Ethanol metabolism by rat precision-cut liver slices.
PCLS were cultured at 24, 48, 72 and 96 h in the presence of
25 mM ethanol (ethanol), and in the presence of both
25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). Since
control PCLS do not metabolize ethanol, the data for
control and control + 4-MP are not shown. Media were
changed every 24 h and assessed for ethanol
concentrations (mmol/mg) by headspace gas
chromatography. Data are expressed as the mean W S.E.M.
Micromoles of ethanol metabolized/(24 h mg) of PCLS
protein of five separate experiments. The addition of 4-MP
significantly inhibited ethanol metabolism at all times,
*P < 0.01.

significantly decreased in PCLS treated with ethanol at 48 and
72 h. The addition of 4-MP maintained total ALDH equivalent
to the levels for 24 to 48 h. Similar results were found for the
low Km ALDH activities showing a decrease by half after 24 h,
and remained consistent for up to 96 h.
CYP2E1, a cytochrome P450 enzyme implicated in ethanolinduced liver injury was examined for protein expression
(Fig. 5A) by immunoblot analysis [9]. At 24 h, the control PCLS
contained about 1/3 the CYP2E1 expression (0.335 relative
counts/mg of t0 PCLS) that was observed in the t0 sample. This
expression decreased slightly at 48 h and then decreased by
approximately 25% every 24 h thereafter. In contrast, the PCLS
exposed to ethanol retained more CYP2E1 expression (0.4835
relative counts/mg of t0 PCLS) at 24 h, with this level decreasing
to those observed for control PCLS slices at 48, 72 and 96 h.
Interestingly, the addition of 4-MP to PCLS in the presence or
absence of ethanol appeared to maintain the CYP2E1 expression levels near to those observed for ethanol PCLS at 24 h.
Protein expression of an enzyme does not necessarily
reflect whether the CYP2E1 was active. Therefore, activity
(Fig. 5B) was assessed using the p-nitrophenol (PNP) oxidation
assay [21]. In general, the profile observed with protein
expression (Fig. 5A) showed a concomitant decrease in activity
(Fig. 5B) in both the control and ethanol PCLS. The addition of
4-MP to control and ethanol PCLS maintained the CYP2E1
activities at levels observed for ethanol PCLS at 24 h for the
first 24 to 48 h. This again reflected the protein expression at
these time points (Fig. 5A). In contrast, the activities began to
decrease at 72 h until they attained control and ethanol PCLS
activity levels by 96 h.
The metabolism of ethanol by ADH and acetaldehyde by
ALDH generates NADH which can result in a reduced redox

Table 1 – Comparison of ADH and ALDH activities in rat precision-cut liver slices lysates from PCLS at t0, 24, 48, 72 and 96 h
were prepared and the activities of ADH and ALDH were compared
Sample (h)

ADH activity

Total ALDH activity

Low Km ALDH activity

Time 0
Control 24
Ethanol 24
Control + 4-MP 24
Ethanol + 4-MP 24

15.39  1.16
10.69  0.71*
11.40  0.58*
12.24  2.35
12.23  2.54

7.59  0.33
4.16  0.16*
4.12  0.18*
4.65  0.36*
4.88  0.27*

1.66  0.09
0.81  0.06*
0.75  0.06*
0.98  0.15*
0.96  0.20*

Control 48
Ethanol 48
Control + 4-MP 48
Ethanol + 4-MP 48

11.54  1.91
9.13  2.04
12.89  3.63
12.04  2.84

3.82  0.41*,$
2.70  0.41*,#,$
4.44  0.44*
4.49  0.35*

0.79  0.09*
1.01  0.13*
1.01  0.24*
1.11  0.21*

Control 72
Ethanol 72
Control + 4-MP 72
Ethanol + 4-MP 72

11.43  0.57*,$
8.01  0.90*,#,$
12.71  1.38*
12.45  1.35*

2.89  0.16*
2.04  0.21*,#,$
3.47  0.36*
4.11  0.44*

0.75  0.04*
0.79  0.17*,$
1.11  0.27*
1.14  0.33*

Control 96
Ethanol 96
Control + 4-MP 96
Ethanol + 4-MP 96

11.01  0.87*,$
7.97  1.59*,#,$
16.09  3.29
10.06  1.43*

2.73  0.14*
2.51  0.14*
3.39  0.44*
3.05  0.27*

0.84  0.18*
1.04  0.18*
1.07  0.35*
1.02  0.12*

*P > 0.05 Significant compared to T = 0. #P > 0.05 Significant compared to control slice. $P > 0.05 Significant compared to control or ethanol 4MP. To determine if ethanol treatment affected these activities, PCLS were incubated in the absence of ethanol (control), presence of 25 mM
ethanol (ethanol), and in the presence of both 25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). All activities are expressed in nmol of
NAD + oxidized/(min mg protein) and are shown as the mean  S.E.M. All determinations were performed in duplicate for each of the five
samples. Significantly decreased compared to the t0 time point, *P < 0.05. Significantly decreased compared to the corresponding control PCLS,
#
P < 0.05. Significantly decreased when compared to the PCLS slices incubated with 4-MP alone (control + 4-MP) or ethanol + 4-MP, $P < 0.05.
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It was important to determine if the PCLS were able to
maintain cellular function and whether ethanol has significant effects on this function. One of the functions that are
commonly measured is the secretion of albumin. As shown in
Fig. 9, albumin is secreted by all PCLS regardless of their
treatment. However, ethanol treatment of PCLS significantly
decreased the secretion by about 50% when compared to
controls. Finally, the addition of 4-MP to the media reversed
the effects of ethanol treatment indicating that the metabolism of ethanol was involved in the decrease in albumin
secretion.

4.

Fig. 4 – Acetaldehyde levels following incubation of rat
precision-cut liver slices with ethanol. PCLS were cultured
24, 48, 72 and 96 h in the presence of 25 mM ethanol
(ethanol). The control and control + 4-MP groups do not
metabolize ethanol to produce acetaldehyde. Additionally,
the addition of both 25 mM ethanol and 0.50 mM 4-MP
(ethanol + 4-MP) resulted in the total inhibition of the
production of acetaldehyde from ethanol. So, the data
from these three groups are not shown. Media was
changed every 24 h and assessed for acetaldehyde
concentrations (mmol) by headspace gas chromatography.
Data are expressed as the mean W S.E.M. of five separate
experiments.

state [25]. To determine the effects of ethanol metabolism on
the PCLS redox state, the lactate/pyruvate (NADH/NAD+) ratio
in PCLS was determined and found to be significantly
increased after ethanol exposure at all times examined
(Fig. 6) when compared to control PCLS. Incubation of the
PCLS in the presence of ethanol and 4-MP completely reversed
the ethanol-induced change in redox state. These results are
similar to those reported with cell lines transfected with ADH
[26,27], from isolated hepatocytes [17], and from the WIF-B cell
line [9].
PCLS were incubated in the presence and absence of both
ethanol and 4-MP for 24, 48, 72 and 96 h, and examined for
cellular triglyceride levels. By 24 h, the levels of triglycerides in
ethanol-treated PCLS were significantly elevated approximately twofold over the control level (Fig. 7). These levels
continued to increase over the 96 h incubation period, reaching a maximum of a 300% increase. The addition of 4-MP in the
presence of ethanol reversed the ethanol-induced increase in
triglyceride content, indicating that the accumulation of
triglycerides was a result of ethanol metabolism.
Oil Red O staining of PCLS treated with ethanol confirms the
biochemical findings discussed above. Fig. 8B shows the
control PCLS after 48 h of culture and there is a small amount
of fatty infiltration as compared to the t0 slice (Fig. 8A). In
contrast, PCLS exposed to ethanol for 48 h showed a
substantial increase in the staining by Oil Red O (Fig. 8C)
similar to that observed in the triglyceride data, that was
abrogated when 4-MP was added to the incubation media
containing ethanol (Fig. 8D).

Discussion

Alcohol abuse results in various forms of liver injury, but
research on the mechanisms of alcoholic liver disease (ALD)
have been hampered by the lack of an appropriate in vitro
culture model in which to conduct in depth and specific
mechanistic studies. Although primary hepatocytes in culture, hepatoma cell lines and WIF-B cells have provided
valuable information, they do not always provide the ability to
study intracellular interactions and the regulatory factors
associated with naturally occurring extracellular matrices,
and in some instances they rapidly lose specific liver gene
expression [3–9]. Others have used liver slices in the past to
attempt to investigate the effects of ethanol on the liver;
however, as with isolated cells and cell lines, these slices
rapidly lost all normal liver function [16,28–31]. Recently,
investigators have developed precision-cut liver slices (PCLS),
incubated under high oxygen content, for investigating the
effects of various toxins on the liver [10,14,32,33]. As described
in this manuscript, we have tested the applicability of using
PCLS as a model for studying the mechanism(s) of alcoholinduced liver injury.
Under the experimental conditions of this study, PCLS
remained functional and viable over a 96-h time period. ATP
was produced and levels of ATP were maintained at high levels
throughout the entire 96 h of incubation. Leakage of LDH was
minimal; however, slight increases were observed at the later
time points. Importantly, albumin was produced and secreted
over the entire time-course, indicating that the PCLS were
functional. Addition of 25 mM ethanol to the PCLS did not
appear to affect their ability to maintain ATP levels, and
leakage of LDH was only slightly increased by ethanol,
indicating that ethanol had only minimal effects on cell
viability. It should be noted, that it was necessary to use the
incubator and roller inserts as described by [34] in order to
maintain PCLS function for longer than 24 h. Additionally, the
V7 medium used for cutting these slices and the addition of
new media daily was imperative in maintaining the viability of
the PCLS. Importantly, in our hands the use of alternative
technological approaches; submerged slices in six-well plates
on a rocker platform [35], Transwell Permeable Supports
(Corning Inc. Acton, MA) on a rocker platform [14], Transwell
plates with nitrocellulose [36], or home-made incubators to
increase oxygen content [32] could only be used for short term
cultures.
A critical aspect of any model designed to study alcoholic
hepatotoxicity is the evaluation of ethanol metabolism. The
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Fig. 5 – (A) CYP2E1 expression in microsomes from rat precision-cut liver slices. PCLS were cultured at t0, 24, 48, 72 and 96 h
in the absence of ethanol (control), absence of ethanol but the addition of 0.50 mM 4-MP (control + 4-MP), presence of 25 mM
ethanol (ethanol), and in the presence of both 25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). Microsomes were
prepared as outlined in Section 2, loaded on SDS-PAGE gels (5 mg protein per lane), and analyzed by immunoblotting and
densitometry as described in Section 2. The data are expressed as the mean W S.E.M. of five separate experiments.
Significantly decreased as compared to t0, #P < 0.001. Significantly increased as compared to the corresponding control
PCLS, *P < 0.05. (B) CYP2E1 activity in microsomes from rat precision-cut liver slices. PCLS were cultured at t0, 24, 48, 72 and
96 h in the absence of ethanol (control), absence of ethanol but the addition of 0.50 mM 4-MP (control + 4-MP), presence of
25 mM ethanol (ethanol), and in the presence of both 25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). Microsomes were
assayed for the presence of CYP2E1 using p-nitrophenol oxidation as described in Section 2. The data are expressed as the
mean W S.E.M. of five separate experiments. Significantly decreased as compared to t0, #P < 0.001. Significantly increased as
compared to the corresponding control PCLS, *P < 0.05.

results for these studies demonstrated that PCLS metabolized
ethanol at virtually the same rate for up to 72 h after which it
decreased slightly for the final 24 h of incubation. Importantly,
the presence of the known inhibitor of ethanol metabolism, 4MP, dramatically reduced the metabolism of ethanol by PCLS.

The rate of ethanol metabolism in PCLS was comparable with
those seen in freshly isolated hepatocytes [17]. Examination of
acetaldehyde (a metabolite of ethanol and a possible mediator
of liver injury) concentrations showed that ethanol metabolism resulted in levels of acetaldehyde ranging from 20 mM at
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Fig. 6 – Redox ratio (lactate/pyruvate) in rat precision-cut
liver slices. PCLS were cultured at 24, 48, 72 and 96 h in the
absence of ethanol (control, solid bars), presence of 25 mM
ethanol (ethanol, open bars), and in the presence of both
25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP-shaded
bar). At the various time points the lactate and pyruvate
concentrations were determined and the redox ratio
calculated. The control + 4-MP group were not different
from the control PCLS (data not shown). The cellular redox
state was determined as described in Section 2. Data are
expressed as the mean lactate/pyruvate (NADH/NAD+)
ratio W S.E.M. of five separate experiments. Significantly
increased for ethanol treated PCLS compared to all other
groups, *P < 0.01.
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48 h to 60 mM at 96 h of incubation. These concentrations are
within the range of values reported for acetaldehyde levels
observed during ethanol metabolism in vivo [37,38]. These
results demonstrated that ethanol metabolism by PCLS are
consistent with the data showing that PCLS were able to
maintain both ADH and ALDH activities during incubation.
ADH activities appeared to remain relatively consistent over
the time-course of incubation; however, ALDH activities did
decrease over the course of these time points, and most likely
explains the increase of acetaldehyde in the media over time.
Another enzyme capable of metabolizing ethanol is
CYP2E1, and this enzyme has been proposed to play a role
in ethanol-induced liver injury [39]. PCLS did express CYP2E1
during incubation; however, the levels and activities of
CYP2E1 were reduced to about 20–40% of the level of a freshly
prepared liver samples. Despite this rather large decrease in
CYP2E1 activity, ethanol metabolism was maintained at a
relatively constant rate, indicating that ethanol metabolism
occurred primarily via the ADH pathway. In addition, the
known in vivo inducing effects of agents, such as ethanol and
4-MP, on CYP2E1 were also observed when PCLS were treated
with these agents.
In order to further evaluate the applicability of PCLS as a
model for ethanol-induced hepatotoxicity, known detrimental
effects of ethanol on hepatic function [1,2,40,41] were tested.
Incubation of PCLS with ethanol resulted in a more reduced
metabolic state, i.e. increased NADH/NAD + ratio (lactate/
pyruvate). Secondly, ethanol treatment impaired the secretion
of albumin by PCLS. Finally, ethanol treatment of PCLS
resulted in a fatty liver. This finding was ascertained by both
morphological and biochemical analysis of triglycerides. In
this regard, triglyceride levels progressively increased during
incubation in the presence of ethanol, reaching an almost

Fig. 7 – Triglyceride concentrations in rat precision-cut liver slices. PCLS were cultured at 24, 48, 72 and 96 h in the absence of
ethanol (control), presence of 25 mM ethanol (ethanol), absence of 25 mM ethanol but in the presence of 0.50 mM 4-MP
(control + 4-MP), and in the presence of both 25 mM ethanol and 0.50 mM 4-MP (ethanol + 4-MP). Data are expressed as the
mean triglyceride levels (mg) per mg of protein in the PCLS W S.E.M. of five separate experiments. Significantly increased for
ethanol treated PCLS as compared to all other groups, *P < 0.05.
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Fig. 8 – Oil Red O staining of PCLS. PCLS were cultured for t0 (A), 48 h in the absence of ethanol (B), 48 h in the presence of
25 mM ethanol (C), and the presence of 25 mM ethanol and 0.50 mM 4-MP (D). Light microscopy photographs were taken at
random on a Nikon Microphot-FXA microscope under 325T magnification. Photographs were taken using a Colorview II
Olympus Camera and Software, and the figures are representative of six separate experiments.

fourfold elevation after 96 h. Inhibition of ethanol metabolism
with 4-MP essentially prevented all of these observed defects
in tested hepatic functions, indicating a prominent role for
ethanol metabolism via ADH in impaired hepatic function by
ethanol.
In summary, PCLS have recently been used by other
investigators studying the toxicological effects of a number of
drugs and toxins [10,13,32,34]. It was the purpose of this study
to determine whether PCLS could be used as a model system to
study the effects of ethanol on the liver. In order to use this
model it was first necessary to demonstrate that the PCLS
could be cultured for an extended period of time without
altering normal biochemical, functional and histological
parameters. This has not been the case with liver slices in
the past [16,30]. However, this model system has been altered
from previous liver slice models by; ensuring the slices are
uniformly very thin (200–300 mm; approximately 8–10 hepatocytes thick), prepared and maintained under highly oxygenated conditions, and continuous changing of the media.
These slices were viable, maintained their histological
appearance, enzyme activities (ADH, ALDH, CYP2E1, etc.),
and their function (albumin secretion) for up to 96 h.
The addition of ethanol to these PCLS produced many of the
same effects that have been observed in both isolated
hepatocytes and in vivo models of chronic ethanol consumption [1,2,9,40,41], including the oxidation of ethanol, acetaldehyde production, fatty liver, altered redox state, and the
decreased secretion of albumin. All of these parameters were

Fig. 9 – Albumin secretion by rat precision-cut liver slices.
PCLS were cultured at 24, 48, 72 and 96 h in the absence of
ethanol (control), presence of 25 mM ethanol (ethanol),
absence of 25 mM ethanol but in the presence of 0.50 mM
4-MP (control + 4-MP), and in the presence of both 25 mM
ethanol and 0.50 mM 4-MP (ethanol + 4-MP). Media were
changed every 24 h and the levels of albumin determined
for each time point. Data are expressed as the mean
albumin levels (ng) per mg of protein in the PCLS W S.E.M.
of five separate experiments. Significantly decreased for
ethanol treated PCLS as compared to all other groups,
*P < 0.05.

biochemical pharmacology 76 (2008) 426–436

reversed in these studies by the addition of an inhibitor of
ethanol metabolism (4-MP), which strongly suggests that this
model has potential for studying the structural and functional
consequences of ethanol-induced liver injury. Additionally,
since all of the cell types are present during the incubation
period in their appropriate conformation and matrix, this
model should be very useful for studying the interactions of
these cells types. Thus, it appears that these PCLS retain many
of the biological functions that are lost when cells from the
liver are isolated and cultured in vitro, and therefore, PCLS
appear to be an attractive and useful model for the study of
pathogenic mechanisms of alcoholic liver disease.
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